Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology
Showing posts with label approves. Show all posts
Showing posts with label approves. Show all posts
Monday, March 12, 2012
FDA approves therapies for AMD, insomnia
Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology
FDA approves preservative-free solution for glaucoma, ocular hypertension
Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology
FDA approves extended-release tablets for type 2 diabetes
Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology
FDA approves extended use of pneumococcal conjugate vaccine as a single dose to adults 50 years and older
Sorry, I could not read the content fromt this page.Sorry, I could not read the content fromt this page.
Subscribe to:
Posts (Atom)